• 1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 4. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Coumarans Coumarans
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Coumarans

Introduction to 2,3-dihydro-1-benzofuran-5-carboxylic acid (CAS No. 76429-73-7) and Its Emerging Applications in Chemical Biology and Medicine

2,3-dihydro-1-benzofuran-5-carboxylic acid, identified by the chemical identifier CAS No. 76429-73-7, is a heterocyclic organic compound that has garnered significant attention in the fields of chemical biology and medicinal chemistry due to its versatile structural framework and promising biological activities. This compound belongs to the benzofuran class, a scaffold that is widely recognized for its presence in numerous pharmacologically active molecules. The unique arrangement of functional groups within its structure, including a carboxylic acid moiety at the 5-position, makes it a valuable building block for the synthesis of more complex derivatives with enhanced therapeutic potential.

The dihydro-1-benzofuran core is particularly noteworthy for its stability and reactivity, which allows for modifications at multiple positions while retaining the inherent pharmacological properties of the parent compound. This flexibility has been exploited in recent years to develop novel compounds targeting various diseases, including neurological disorders, inflammatory conditions, and cancer. The carboxylic acid group at the 5-position further enhances its utility as a synthetic intermediate, enabling further derivatization through esterification, amidation, or other functional group transformations.

Recent advancements in computational chemistry and high-throughput screening have accelerated the discovery of new derivatives of 2,3-dihydro-1-benzofuran-5-carboxylic acid. These studies have revealed that structural modifications at the 2- and 3-positions of the benzofuran ring can significantly alter the biological activity of the molecule. For instance, substituents such as halogens or alkyl groups have been shown to enhance binding affinity to specific protein targets, leading to more potent pharmacological effects.

In particular, research has highlighted the potential of 2,3-dihydro-1-benzofuran-5-carboxylic acid derivatives as modulators of enzyme activity. Several studies have demonstrated their ability to inhibit key enzymes involved in metabolic pathways relevant to inflammation and oxidative stress. These findings are particularly exciting given the growing recognition of metabolic dysregulation as a contributing factor in chronic diseases. The carboxylic acid functionality at the 5-position serves as a critical anchor for interactions with enzyme active sites, facilitating precise molecular recognition.

The dihydro-1-benzofuran scaffold is also known for its role in central nervous system (CNS) drug discovery. Compounds derived from this structure have shown promise as potential treatments for neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. The ability of these molecules to cross the blood-brain barrier while maintaining stability has made them attractive candidates for further development. Additionally, their interaction with neurotransmitter receptors and ion channels suggests they may modulate neuronal signaling pathways in ways that could ameliorate cognitive decline.

Another area where 2,3-dihydro-1-benzofuran-5-carboxylic acid derivatives have found utility is in oncology research. Preclinical studies have indicated that certain analogs exhibit inhibitory effects on kinases and other enzymes overexpressed in cancer cells. The carboxylic acid group at the 5-position allows for further derivatization into prodrugs or targeted delivery systems, which could improve bioavailability and reduce side effects associated with systemic administration.

The synthesis of 2,3-dihydro-1-benzofuran-5-carboxylic acid itself is well-documented in synthetic organic chemistry literature. Common approaches include cyclization reactions involving readily available precursors such as phenols and ketones. Advances in catalytic methods have further streamlined these processes, enabling higher yields and improved scalability. These synthetic strategies are crucial for producing sufficient quantities of the compound for both academic research and industrial applications.

In conclusion, 2,3-dihydro-1-benzofuran-5-carboxylic acid (CAS No. 76429-73-7) represents a structurally intriguing molecule with broad applicability across multiple therapeutic areas. Its unique combination of reactivity and biological activity makes it an indispensable tool for medicinal chemists seeking to develop novel therapeutics. As research continues to uncover new derivatives and applications, this compound is poised to play an increasingly significant role in addressing some of today’s most pressing medical challenges.

• 895240-77-4(4-Ethyl-3-(3-methoxypropoxyl)benzoicacid)
• 135901-81-4(3-Acetyl-4-propoxybenzoic acid)
• 911115-52-1(Benzoic acid, 4-ethyl-3-(3-hydroxypropoxy)-)
• 100482-30-2(Benzoic acid,4-propoxy-3,5-dipropyl-)
• 301836-57-7(2,3-dihydro-1-benzofuran-6-carboxylic acid)
• 35700-40-4(2,3-dihydro-1-benzofuran-7-carboxylic acid)
• 883546-53-0(2-(2-Phenylethoxy)benzoic Acid)
• 223699-95-4(Benzoic acid, 3-acetyl-4-ethoxy- (9CI))
• 628331-51-1(Benzaldehyde, 3-ethyl-2-(phenylmethoxy)-)
• 588702-80-1(Methyl 2,3-dihydrobenzofuran-5-carboxylate)